Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Meta Platforms, Raises Price Target to $130

Morgan Stanley Maintains Equal-Weight on Meta Platforms, Raises Price Target to $130

Morgan Stanley analyst Brian Nowak maintains Meta Platforms (NASDAQ:META) with a Equal-Weight and raises the price target from $100 to $130.

byBenzinga Newsdesk

January 18, 2023

1 minute read

Morgan Stanley analyst Brian Nowak maintains Meta Platforms (NASDAQ:META) with a Equal-Weight and raises the price target from $100 to $130.

Novel Compound Begins Clinical Testing For Potential Treatment Of Multiple Sclerosis

By Lara Goldstein

April 17, 3:52 PM

FSD Pharma Inc. (NASDAQ: HUGE) has dosed the first subjects in its first clinical trial assessing the New Chemical Entity (NCE) Lucid-21-302, or Lucid-MS, targetting multiple sclerosis.

HUGE

UK Law Enforcement Seeks Elite Cryptocurrency Investigator To Join New Crypto Unit

By Justin Roberti

January 4, 3:39 PM

If you live in the United Kingdom and are hoping to work in Web3 in 2023, there is a new opportunity possible for you.

BTC

News

Novartis Expands Production Of Pluvicto With Addition Of Its Largest And Most Advanced Radioligand Therapy Manufacturing Facility In Indianapolis

By Benzinga Newsdesk

January 5, 10:31 AM

FDA approval of the company's second US Radioligand Therapy (RLT) manufacturing facility increases RLT production capacity to 250,000 doses in 2024 and beyond New 70,000-square foot RLT facility is the company's

NVS

RBC Capital Maintains Sector Perform on Yum Brands, Raises Price Target to $132

By Benzinga Newsdesk

December 16, 9:20 AM

RBC Capital analyst Christopher Carril maintains Yum Brands (NYSE:YUM) with a Sector Perform and raises the price target from $128 to $132.

YUM

Morgan Stanley Maintains Equal-Weight on Meta Platforms, Raises Price Target to $130

Related Posts

Novel Compound Begins Clinical Testing For Potential Treatment Of Multiple Sclerosis

UK Law Enforcement Seeks Elite Cryptocurrency Investigator To Join New Crypto Unit

Novartis Expands Production Of Pluvicto With Addition Of Its Largest And Most Advanced Radioligand Therapy Manufacturing Facility In Indianapolis

RBC Capital Maintains Sector Perform on Yum Brands, Raises Price Target to $132